Efficacy of Bevacizumab to Reduce Lid Margin Vascularity and Alteration in Tear Film Status. Annals KEMU [Internet]. 2021 Nov. 4 [cited 2024 Dec. 21];27(Special Issue (Jul-Sep):368-71. Available from: https://annalskemu.org/journal/index.php/annals/article/view/4656